Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Beule, Dieter Dr. (2) Cakmak-Görür, Nese Dr. (1) Daniel, Peter Prof. Dr. (2) Dhamodaran, Arunraj (1) Kammertöns, Thomas Dr. (6) Kopp, Joachim Dr. (2) Leisegang, Matthias Prof. Dr. rer. nat. (3) Lorenz, Felix Dr. (1) Marko, Lajos Dr. (1) Pezzutto, Antonio Prof. Dr. (5) Poncette, Lucia (1) Rhein, Simone Dr. (1) Siffrin, Volker (1) Stein, Ulrike Prof. Dr. (1) Uckert, Wolfgang Prof. Dr. (4) Walther, Wolfgang Prof. Dr. (1) Willimsky, Gerald Dr. (4) (-) Blankenstein, Thomas Prof. Dr. (23) Bioinformatics and Omics Data Science (1) Biologie maligner Lymphome (11) Entwicklungsneurobiologie (1) Genetik und Genomik von Herz- Kreislauferkrankungen (1) (-) Molekulare Immunologie und Gentherapie (23) Proteom Dynamik (1) Strukturbiologie Membran-assoziierter Prozesse (1) Systembiologie von Gen-regulatorischen Elementen (1) Translational Bioinformatics (2) 1992 (4) 1993 (7) 1994 (5) 1995 (8) 1996 (6) 1997 (9) (-) 1998 (9) 1999 (2) 2000 (8) 2001 (5) 2002 (5) 2003 (9) 2004 (8) 2005 (10) 2006 (1) 2007 (5) 2008 (5) 2009 (2) 2010 (7) (-) 2011 (5) 2012 (6) 2013 (11) 2014 (3) (-) 2015 (3) 2016 (4) 2017 (6) 2018 (4) (-) 2019 (6) 2021 (4) 2022 (6) 2023 (4) 2024 (2) 23 Ergebnisse: Active Filter: Blankenstein, Thomas Prof. Dr.Molekulare Immunologie und Gentherapie 1998201120152019 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. April 2011 / Gene Ther Allogeneic gene-modified tumor cells (RCC-26/IL-7/CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study J. Westermann A. Floercken G. Willimsky A. van Lessen J. Kopp A. Takvorian K. Joehrens A. Lukowsky C. Schoenemann B. Sawitzki H. Pohla R. Frank B. Doerken D.J. Schendel T. Blankenstein A. Pezzutto 13. Dezember 2011 / Canc Cell Oncogene-targeting T cells reject large tumors while oncogene inactivation selects escape variants in mouse models of cancer K. Anders C. Buschow A. Herrmann A. Milojkovic C. Loddenkemper T. Kammertoens P. Daniel H. Yu J. Charo T. Blankenstein 15. Januar 2011 / Int J Cancer Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis D. Briesemeister D. Sommermeyer C. Loddenkemper R. Loew W. Uckert T. Blankenstein T. Kammertoens 28. Juli 2011 / Blood The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processed J. Popovic L.P. Li P.M. Kloetzel M. Leisegang W. Uckert T. Blankenstein 01. November 2011 / Eur J Immunol Visualizing the dynamic of adoptively transferred T cells during the rejection of large established tumors J. Charo C. Perez C. Buschow A. Jukica M. Czeh T. Blankenstein 27. November 2019 / BMC Med Genomics Identification and ranking of recurrent neo-epitopes in cancer E. Blanc M. Holtgrewe A. Dhamodaran C. Messerschmidt G. Willimsky T. Blankenstein D. Beule 02. September 2019 / BMC Bioinformatics SigsPack, a package for cancer mutational signatures F. Schumann E. Blanc C. Messerschmidt T. Blankenstein A. Busse D. Beule 07. Februar 2019 / Front Immunol Interferon-γ receptor signaling in dendritic cells restrains spontaneous proliferation of CD4(+) T cells in chronic lymphopenic mice L. Knop C. Frommer D. Stoycheva K. Deiser U. Kalinke T. Blankenstein T. Kammertoens I.R. Dunay T. Schüler 24. März 2019 / OncoImmunology Localization-associated immune phenotypes of clonally expanded tumor-infiltrating T cells and distribution of their target antigens in rectal cancer L. Penter K. Dietze J. Ritter M.F. Lammoglia Cobo J. Garmshausen F. Aigner L. Bullinger H. Hackstein S. Wienzek-Lischka T. Blankenstein M. Hummel K. Dornmair L. Hansmann 02. Januar 2019 / J Clin Invest Effective NY-ESO-1-specific MHC II-restricted T cell receptors from antigen-negative hosts enhance tumor regression L. Poncette X. Chen F.K.M. Lorenz T. Blankenstein Seitennummerierung Erste Seite « First Vorherige Seite ‹ Previous Seite 1 Aktuelle Seite 2 Seite 3 Nächste Seite Next › Letzte Seite Last »
01. April 2011 / Gene Ther Allogeneic gene-modified tumor cells (RCC-26/IL-7/CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study J. Westermann A. Floercken G. Willimsky A. van Lessen J. Kopp A. Takvorian K. Joehrens A. Lukowsky C. Schoenemann B. Sawitzki H. Pohla R. Frank B. Doerken D.J. Schendel T. Blankenstein A. Pezzutto
13. Dezember 2011 / Canc Cell Oncogene-targeting T cells reject large tumors while oncogene inactivation selects escape variants in mouse models of cancer K. Anders C. Buschow A. Herrmann A. Milojkovic C. Loddenkemper T. Kammertoens P. Daniel H. Yu J. Charo T. Blankenstein
15. Januar 2011 / Int J Cancer Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis D. Briesemeister D. Sommermeyer C. Loddenkemper R. Loew W. Uckert T. Blankenstein T. Kammertoens
28. Juli 2011 / Blood The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processed J. Popovic L.P. Li P.M. Kloetzel M. Leisegang W. Uckert T. Blankenstein
01. November 2011 / Eur J Immunol Visualizing the dynamic of adoptively transferred T cells during the rejection of large established tumors J. Charo C. Perez C. Buschow A. Jukica M. Czeh T. Blankenstein
27. November 2019 / BMC Med Genomics Identification and ranking of recurrent neo-epitopes in cancer E. Blanc M. Holtgrewe A. Dhamodaran C. Messerschmidt G. Willimsky T. Blankenstein D. Beule
02. September 2019 / BMC Bioinformatics SigsPack, a package for cancer mutational signatures F. Schumann E. Blanc C. Messerschmidt T. Blankenstein A. Busse D. Beule
07. Februar 2019 / Front Immunol Interferon-γ receptor signaling in dendritic cells restrains spontaneous proliferation of CD4(+) T cells in chronic lymphopenic mice L. Knop C. Frommer D. Stoycheva K. Deiser U. Kalinke T. Blankenstein T. Kammertoens I.R. Dunay T. Schüler
24. März 2019 / OncoImmunology Localization-associated immune phenotypes of clonally expanded tumor-infiltrating T cells and distribution of their target antigens in rectal cancer L. Penter K. Dietze J. Ritter M.F. Lammoglia Cobo J. Garmshausen F. Aigner L. Bullinger H. Hackstein S. Wienzek-Lischka T. Blankenstein M. Hummel K. Dornmair L. Hansmann
02. Januar 2019 / J Clin Invest Effective NY-ESO-1-specific MHC II-restricted T cell receptors from antigen-negative hosts enhance tumor regression L. Poncette X. Chen F.K.M. Lorenz T. Blankenstein